KYleena Satisfaction Study / Observational Study on User Satisfaction With the Levonorgestrel Intrauterine Delivery System Kyleena (LNG-IUS 12) in New Contraceptive Users and After Switching From Another Contraceptive Method
Phase of Trial: Phase IV
Latest Information Update: 12 Oct 2017
At a glance
- Drugs Levonorgestrel (Primary)
- Indications Pregnancy
- Focus Therapeutic Use
- Acronyms KYSS
- Sponsors Bayer
- 08 Aug 2017 Planned End Date changed from 30 Sep 2019 to 31 Oct 2019.
- 10 Jul 2017 Status changed from not yet recruiting to recruiting.
- 12 Jun 2017 New trial record